AIMT - Aimmune Therapeutics Inc. (AIMT) CEO Jayson Dallas on Q2 2019 Results - Earnings Call Transcript
Aimmune Therapeutics, Inc. (AIMT)
Q2 2019 Earnings Conference Call
August 8, 2019 4:30 P.M. ET
Company Participants
Eric Bjerkholt - Chief Financial Officer
Jayson Dallas - President and Chief Executive Officer
Dan Adelman - Chief Medical Officer
Andrew Oxtoby - Chief Commercial Officer
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Chris Raymond - Piper Jaffray
Liana Moussatos - Wedbush Securities
Zegbeh Jallah - ROTH Capital Partners
Justin Burns - RBC Capital Markets
Adrian Garcia - Credit Suisse
Corinne Jenkins - Goldman Sachs
Presentation
Operator
Good afternoon ladies and gentlemen and welcome to the Aimmune